Diabetic Neuropathy. Friedrich A. Gries
JM, TenVoorde BJ, Bertelsmann FW, Kostense PJ, Stehouwer CDA, Heine RJ, Nijpels G, Heethaar RM, Bouter LM. Glucose tolerance and other determinants of cardiovascular autonomic function: the Hoorn Study. Diabetologia 2000; 43: 561-70.
[109] Smulders YM, Jager A, Gerritsen J, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CDA. Cardiovascular autonomic function is associated with (micro-)alburninuria in elderly Caucasian subjects with impaired glucose tolerance or type 2 diabetes. Hoorn Study. Diabetes Care 2000; 23: 1369-74.
[110] Marre M. Genetics and the prediction of complications in type 1 diabetes. Diabetes Care 1999; 22 (Suppl 2): B53-58.
[111] Vague P, Dufayet D, Coste T, Moriscot C, Jannot MF, Raccah D. Association of diabetic neuropathy with NA/K-ATPase gene polymorphism. Diabetologia 1997; 40: 506-11.
[112] Heesom AE, Millward A, Demaine AG. Susceptibility to diabetic neuropathy in patients with insulin dependent diabetes mellitus is associated with a polymorphism at the 5′ end of the aldose reductase gene. J Neurol Neurosurg Psychiatry 1998; 64: 213-6.
[113] Ichikawa F, Yamada K, Ishiyama-Shigemoto S, Yuan X, Nonaka K. Association of an (A-C)n dinucleotide repeat polymorphic marker at the 5′-region of the aldose reductase gene with retinopathy but not with nephropathy or neuropathy in Japanese patients with type 2 diabetes mellitus, Diabet Med 1999; 16: 744-8.
[114] Forsblom CM, Sane T, Groop P-H, Tötterman KJ, Kallio M, Saloranta C, Laasonen L, Summanen P, Lepäntalo M, Laatikainen L, Matikainen E, Teppo A-M, Koskimies S, Groop L. Risk factors for mortality in type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DRDiabetologia 1998; 41: 1253-62.
[115] Reichard P, Pihl M. Mortality and treatment side-effects during long-term intensified conventional insulin treatment in the Stockholm Diabetes Intervention Study. Diabetes 1994; 43: 313-7.
[116] Coppini DV, Bowtell PA, Weng C, Young PJ, Sönksen PH. Showing neuropathy is related to increased mortality in diabetic patients - a survival analysis using an accelerated failure time model. J Clin Epidemiol 2000; 53: 519-23.
[117] Navarro X, Kennedy WR, Aeppli D, Sutherland DER. Neuropathy and mortality in diabetes: influence of pancreas transplantation. Muscle Nerve 1996; 19: 1009-16.
[118] Boyko EJ, Ahroni JH, Smith DG, Davignon D. Increased mortality associated with diabetic foot ulcer. Diabet Med 1996; 13: 967-72.
[119] Ewing DJ, Campbell IW, Clarke BF. The natural history of diabetic autonomic neuropathy. Q J Med 1980; 49: 95-108.
[120] Hasslacher C, Bässler G. Prognose der kardialen autonomen Neuropathie bei Diabetikern. Münch Med Wochenschr 1983; 125: 375-7.
[121] Navarro X, Kennedy WR, Loewenson RB, Sutherland DER. Influence of pancreas transplantation on cardiorespiratory reflexes, nerve conduction, and mortality in diabetes. Diabetes 1990; 39: 802-6.
[122] O'Brien IA, McFadden JP, Corral RJM. The influence of autonomic neuropathy on mortality in insulin-dependent diabetes. Q J Med 1991; 79: 495-502.
[123] Ewing DJ, Boland O, Neilson JMM, Cho CG, Clarke BF. Autonomic neuropathy. QT interval lengthening, and unexpected deaths in male diabetic patients. Diabetologia 1991; 34: 182-5.
[124] Jermendy G, Toth L, Vörös P, Koltai MZ, Pogatsa G. Cardiac autonomic neuropathy and QT interval length. A follow-up study in diabetic patients. Acta Cardiol 1991; 46: 189-200.
[125] Rathmann W, Ziegler D, Jahnke M, Haastert B, Cries FA. Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med 1993; 10: 820-4.
[126] Luft D, Rak R, Renn W, Konz K, Eggstein M. Diabetische autonome Neuropathie: Verlauf und prognostische Bedeutung kardiovaskulärer Reflexteste. Diab Stoffw 1993; 2: 239-44.
[127] Orchard TJ, Lloyd CE, Maser RE, Kuller LH. Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Res Clin Pract 1996; 34 (Suppl): S165-171.
[128] Veglio M, Sivieri R, Chinaglia A, Scaglione L, Cavallo-Perin P. QT interval prolongation and mortality in type 1 diabetic patients: a 5-year cohort prospective study. Neuropathy Study Group of the Italian Society of the Study of Diabetes, Piemonte Affiliate. Diabetes Care 2000; 23: 1381-3.
[129] Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability, standards of measurement, physiological interpretation, and clinical use. Circulation 1996; 93: 1043-65.
[130] Jacobi RM, Nesto RW. Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis. J Am Coll Cardiol 1992; 20: 736-44.
[131] Page MMcB, Watkins PJ. Cardiorespiratory arrest and diabetic autonomic neuropathy. Lancet 1978; i: 14-6.
[132] Whitsel EA, Boyko EJ, Siscovick DS. Reassessing the role or QTc in the diagnosis of autonomic failure among patients with diabetes. A meta-analysis. Diabetes Care 2000; 23: 241-7.
[133] Anonymous. Neural mechanisms in sudden cardiac death: insights from long QT syndrome. Lancet 1991; 338: 1181-2.
[134] Pozzati A, Pancaldi LG, Di Pasquale G, Pinelli G, Bugiardini R. Transient sympathovagal imbalance triggers “ischemic” sudden death in patients undergoing electrocardiographic Holter monitoring. J Am Coll Cardiol 1996; 27: 847-52.
[135] Fei L, Anderson MH, Katritsis D, Sneddon J, Statters DJ, Malik M, Camm AJ. Decreased heart rate variability in survivors of sudden cardiac death not associated with coronary artery disease. Br Heart J 1994; 71: 16-21.
[136] Bikkina M, Alpert MA, Mukerji R, Mulekar M, Cheng B-Y, Mukerji V. Diminished short-term heart rate variability predicts inducible ventricular tachycardia. Chest 1998; 113: 312-6.
[137] Algra A, Tijssen JGP, Roelandt JRTC, Pool J, Lubsen J. Heart rate variability from 24-hour electrocardiography and the 2-year risk for sudden death. Circulation 1993; 88: 180-5.
[138] Dekker JM, Schouten EG, Klootwijk P, Pool J, Swenne CA, Kromhout D. Heart rate variability from short electrocardiographic recordings predicts mortality from all causes in middle-aged and elderly men. Zutphen Study. Am J Epidemiol 1997; 145: 899-908.
[139] Masaki KH, Schatz IJ. Burchfiel CM, Sharp DS, Chiu D, Foley D, Curb JD. Orthostatic hypotension predicts mortality in elderly men: the Honolulu Heart Program. Circulation 1998; 98: 2290-5.
[140] Rees PJ, Cochrane GM, Prior JG, Clark TJH. Sleep apnea in diabetic patients with autonomic neuropathy. J R Soc Med 1981; 74: 192-5.
[141] Neumann C, Martinez D, Schmid H. Nocturnal oxygen desaturation in diabetic patients with severe autonomic neuropathy. Diabetes Res Clin Pract 1995; 28: 97-102.
[142] Sobotka PA, Liss HP, Vinik AI. Impaired hypoxic ventilatory drive in diabetic patients with autonomic neuropathy. J Clin Endocrinol Metab 1986; 62: 658-63.
[143] Wanke T, Abrahamian H, Lahrmann H, Formanek D, Merkle M, Auinger M, Zwick H, Irsigler K. No effect of naloxone on ventilatory response to progressive hypercapnia in IDDM patients. Diabetes 1993; 42: 282-7.
[144] Tantucci C, Scionti L, Bottini P, Dottorini ML, Puxeddu E. Casucci G, Sorbini CA. Influence of autonomic neuropathy of different severities on the hypercapnic drive to breathing in diabetic patients. Chest 1997; 112: 145-53.
[145] Chaudhuri TK, Fink S. Prognostic implications of gastroparesis in patients with diabetes mellitus. Clin Auton Res 1992; 2: 221-4.
[146] Kong M-F, Horowitz M, Jones KL, Wishart JM, Harding PE. Natural history of diabetic gastroparesis. Diabetes Care 1999; 22: 503-7.
4 Pathogenesis and Pathology of Diabetic Neuropathy
Histopathology